Journal of Substance Abuse Treatment
Volume 28, Issue 4 , Pages 297-304 , June 2005

Increases in hyperactive–impulsive symptoms predict relapse among smokers in nicotine replacement therapy

Received 14 May 2004 ,Revised 13 January 2005 ,Accepted 25 February 2005.

References 

  1. Barkley RA, Murphy KR. Attention-deficit hyperactivity disorder: A clinical workbook. 2nd ed.. New York, NY: Guilford Press; 1998;
  2. Barkley RA, Murphy KR, Bush T. Time perception and reproduction in young adults with attention deficit hyperactivity disorder. Neuropsychology. 2001;15:351–360
  3. Barkley RA, Murphy KR, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics. 1996;98:1089–1095
  4. Benowitz N. Pharmacology of nicotine: Addiction and therapeutics. Annual Review of Pharmacology and Toxicology. 1996;36:597–613
  5. Bizarro L, Stolerman IP. Attentional effects of nicotine and amphetamine in rats at different levels of motivation. Psychopharmacology (Berlin). 2003;170:271–277
  6. Blondel A, Sanger DJ, Moser PC. Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: Antagonist studies. Psychopharmacology (Berlin). 2000;149:293–305
  7. Brandon TH, Tiffany ST, Obremski KM, Baker TB. Postcessation cigarette use: The process of relapse. Addictive Behaviors. 1990;15:105–114
  8. Brown R, Burgess E, Sales S, Whiteley J. Reliability and validity of a smoking timeline follow-back interview. Psychology of Addictive Behaviors. 1998;12:101–112
  9. Carroll KM, Rounsaville BJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Comprehensive Psychiatry. 1993;34:75–82
  10. Conners CK, Levin ED, Sparrow E, Hinton SC, Erhardt D, Meck WH, et al. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacology Bulletin. 1996;32:67–73
  11. Dinn WM, Aycicegi A, Harris CL. Cigarette smoking in a student sample: Neurocognitive and clinical correlates. Addictive Behaviors. 2004;29:107–126
  12. DSM-IV Task Force . Diagnostic and statistical manual for mental disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994;
  13. Du Paul GJ, Power TJ, Anastopoulous AD, Reid R. ADHD rating scale-IV; checklists, norms, and clinical interpretation. New York, NY: Guilford Press; 1998;
  14. Fiore MC, Novotny TE, Pierce JP, Giovino GA, Hatziandreu EJ, Newcomb PA, et al. Methods used to quit smoking in the United States. Do cessation programs help?. Journal of the American Medical Association. 1990;263:2760–2765
  15. Fiore MC, Pierce JP, Remington PL, Fiore BJ. Cigarette smoking: The clinician's role in cessation, prevention, and public health. Disease-a-Month. 1990;36:181–242
  16. Hahn B, Stolerman IP. Nicotine-induced attentional enhancement in rats: Effects of chronic exposure to nicotine. Neuropsychopharmacology. 2002;27:712–722
  17. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction. 1991;86:1119–1127
  18. Henningfield J. Nicotine medications for smoking cessation. New England Journal of Medicine. 1995;333:1196–1203
  19. Henningfield JE, Keenan RM. Nicotine delivery kinetics and abuse liability. Journal of Consulting and Clinical Psychology. 1993;61:743–750
  20. Hughes J. Pharmacotherapy for smoking cessation: Unvalidated assumptions, anomalies, and suggestions for future research. Journal of Consulting and Clinical Psychology. 1993;61:751–760
  21. Hughes JR. Tobacco withdrawal in self-quitters. Journal of Consulting and Clinical Psychology. 1992;60:689–697
  22. Hughes JR, Keely JP, Niaura R, Ossip-Klein DJ, Richmond RL, Swan GE. Measure of abstinence in clinical trials: Issues and recommendations. Nicotine & Tobacco Research. 2003;5:13–25
  23. Johansson CJ, Olsson P, Bende M, Carlsson T, Gunnarsson PO. Absolute bioavailability of nicotine applied to different nasal regions. European Journal of Clinical Pharmacology. 1991;41:585–588
  24. Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. Journal of Learning Disabilities. 1998;31:533–544
  25. Lerman C, Audrain J, Orleans CT, Boyd R, Gold K, Main D, et al. Investigation of mechanisms linking depressed mood to nicotine dependence. Addictive Behaviors. 1996;21:9–19
  26. Lerman C, Audrain J, Tercyak K, Hawk LW, Bush A, Crystal-Mansour S, et al. Attention-deficit hyperactivity disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine & Tobacco Research. 2001;3:353–359
  27. Lerman C, Roth D, Kaufmann V, Audrain J, Hawk L, Liu A, et al. Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug and Alcohol Dependence. 2002;67:219–223
  28. Levin ED, Conners CK, Silva D, Hinton SC, Meck WH, March J, et al. Transdermal nicotine effects on attention. Psychopharmacology (Berlin). 1998;140:135–141
  29. Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meck WH, et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berlin). 1996;123:55–63
  30. Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug and Alcohol Dependence. 1998;52:15–25
  31. Mancuso G, Warburton DM, Melen M, Sherwood N, Tirelli E. Selective effects of nicotine on attentional processes. Psychopharmacology (Berlin). 1999;146:199–204
  32. Mirza NR, Stolerman IP. Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology (Berlin). 1998;138:266–274
  33. Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments. Comprehensive Psychiatry. 1996;37:393–401
  34. Murphy P, Schachar R. Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. American Journal of Psychiatry. 2000;157:1156–1159
  35. Pomerleau CS, Downey KK, Snedecor SM, Mehringer AM, Marks JL, Pomerleau OF. Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology. Addictive Behavior. 2003;28:1149–1157
  36. Pomerleau CS, Marks JL, Pomerleau OF. Who gets what symptom? Effects of psychiatric cofactors and nicotine dependence on patterns of smoking withdrawal symptomatology. Nicotine & Tobacco Research. 2000;2:275–280
  37. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. Journal of Substance Abuse. 1995;7:373–378
  38. Radloff L. The CES-D scale: A new self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1:385–401
  39. Schubiner H, Tzelepis A, Milberger S, Lockhart N, Kruger M, Kelley BJ, et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. Journal of Clinical Psychiatry. 2000;61:244–251
  40. Shiffman S, Paty JA, Gnys M, Kassel JA, Hickcox M. First lapses to smoking: Within-subjects analysis of real-time reports. Journal of Consulting and Clinical Psychology. 1996;64:366–379
  41. Spitzer R, Williams J, Gibbon M. Structured Clinical Interview for DSM-III-R-Non-Patient Edition (SCID-NP Version 1.0). Arlington, VA: American Psychiatric Press; 1990;
  42. Szatmari P, Offord DR, Boyle MH. Ontario Child Health Study: Prevalence of attention deficit disorder with hyperactivity. Journal of Child Psychology and Psychiatry. 1989;30:219–230
  43. Tarter RE, McBride H, Buonpane N, Schneider DU. Differentiation of alcoholics. Childhood history of minimal brain dysfunction, family history, and drinking pattern. Archives of General Psychiatry. 1977;34:761–768
  44. Watson D, Clark L, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology. 1988;54:1063–1070

PII: S0740-5472(05)00042-5

doi: 10.1016/j.jsat.2005.02.002

Journal of Substance Abuse Treatment
Volume 28, Issue 4 , Pages 297-304 , June 2005

Article Tools

* Image Usage & Resolution